Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABBV, ALL, NextEra Energy, UHAL.B, AER, and represent 38.85% of Bruce & Co's stock portfolio.
- Added to shares of these 2 stocks: LYB, FATE.
- Reduced shares in these 7 stocks: T, CMS, DUK, KOD, LVTX, Accelerate Diagnostic, EDAP.
- Sold out of its positions in Accelerate Diagnostic, LVTX.
- Bruce & Co was a net seller of stock by $-11M.
- Bruce & Co has $323M in assets under management (AUM), dropping by 4.69%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bruce & Co
Bruce & Co holds 39 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abbvie Common (ABBV) | 9.1 | $30M | 128k | 231.54 |
|
|
| Allstate Common (ALL) | 8.3 | $27M | 126k | 214.65 |
|
|
| Nextera Energy Common | 7.4 | $24M | 315k | 75.49 |
|
|
| Uhaul B Common (UHAL.B) | 7.1 | $23M | 452k | 50.90 |
|
|
| AerCap Holdings Common (AER) | 6.9 | $22M | 184k | 121.00 |
|
|
| Duke Energy Common (DUK) | 6.0 | $19M | -11% | 156k | 123.75 |
|
| Abbott Common (ABT) | 5.5 | $18M | 134k | 133.94 |
|
|
| Merck Common | 5.0 | $16M | 193k | 83.93 |
|
|
| XCEL Energy Common (XEL) | 4.9 | $16M | 195k | 80.65 |
|
|
| At & T Common (T) | 4.6 | $15M | -22% | 523k | 28.24 |
|
| Insteel Common (IIIN) | 4.1 | $13M | 343k | 38.34 |
|
|
| CMS Energy Common (CMS) | 3.5 | $11M | -20% | 156k | 73.26 |
|
| Apple Common (AAPL) | 3.1 | $9.9M | 39k | 254.63 |
|
|
| Newmont Common (NEM) | 2.6 | $8.4M | 100k | 84.31 |
|
|
| Avista Common (AVA) | 2.4 | $7.6M | 202k | 37.81 |
|
|
| Pfizer Common (PFE) | 2.1 | $6.9M | 272k | 25.48 |
|
|
| Bunge Common (BG) | 2.0 | $6.5M | 80k | 81.25 |
|
|
| Archer Daniels Common (ADM) | 1.8 | $6.0M | 100k | 59.74 |
|
|
| Kodiak Sciences Common (KOD) | 1.4 | $4.6M | -13% | 279k | 16.37 |
|
| Vicor Common (VICR) | 1.4 | $4.5M | 90k | 49.72 |
|
|
| Uhaul Common (UHAL) | 1.3 | $4.2M | 74k | 57.07 |
|
|
| Darling Ingredients Common (DAR) | 1.3 | $4.0M | 131k | 30.87 |
|
|
| Chemours Common (CC) | 1.2 | $4.0M | 250k | 15.84 |
|
|
| Supernus Common (SUPN) | 1.2 | $3.9M | 82k | 47.79 |
|
|
| Lyondellbasell Common (LYB) | 0.9 | $2.9M | +50% | 60k | 49.04 |
|
| Rli Common (RLI) | 0.8 | $2.7M | 41k | 65.22 |
|
|
| Personalis Common (PSNL) | 0.5 | $1.6M | 253k | 6.52 |
|
|
| Eli Lilly Common (LLY) | 0.5 | $1.5M | 2.0k | 763.00 |
|
|
| Venture Global Common (VG) | 0.4 | $1.4M | 100k | 14.19 |
|
|
| XM Sirius Common | 0.4 | $1.3M | 56k | 23.27 |
|
|
| Bausch Health Common | 0.3 | $1.1M | 171k | 6.45 |
|
|
| Mannkind Common (MNKD) | 0.3 | $1.0M | 195k | 5.37 |
|
|
| Edap Common (EDAP) | 0.3 | $1.0M | -20% | 439k | 2.31 |
|
| Fate Theraputics Common (FATE) | 0.3 | $919k | +69% | 729k | 1.26 |
|
| Ashland Common | 0.2 | $719k | 15k | 47.91 |
|
|
| 908 Devices Common (MASS) | 0.2 | $598k | 68k | 8.76 |
|
|
| Caribou Biosciences Common (CRBU) | 0.2 | $583k | 250k | 2.33 |
|
|
| Viatris Common (VTRS) | 0.2 | $577k | 58k | 9.90 |
|
|
| WEC Energy Common (WEC) | 0.1 | $452k | 3.9k | 114.59 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2025 Q3 filed Nov. 13, 2025
- Bruce & Co 2025 Q2 filed Aug. 14, 2025
- Bruce & Co 2025 Q1 filed May 14, 2025
- Bruce & Co 2024 Q4 filed Feb. 11, 2025
- Bruce & Co 2024 Q3 filed Nov. 14, 2024
- Bruce & Co 2024 Q2 filed Aug. 9, 2024
- Bruce & Co 2024 Q1 filed May 13, 2024
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022
- Bruce & Co 2022 Q2 filed Aug. 9, 2022
- Bruce & Co 2022 Q1 filed May 11, 2022
- Bruce & Co 2021 Q4 filed Feb. 16, 2022